Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.54M Buy
12,893
+85
+0.7% +$30.3K 1.6% 14
2025
Q4
$4.19M Sell
12,808
-45
-0.4% -$14.3K 1.48% 14
2025
Q3
$3.63M Buy
12,853
+351
+3% +$102K 1.28% 22
2025
Q2
$3.49M Buy
12,502
+180
+1% +$51K 1.34% 20
2025
Q1
$3.84M Buy
12,322
+521
+4% +$154K 1.6% 13
2024
Q4
$3.08M Sell
11,801
-49
-0.4% -$14.5K 1.28% 20
2024
Q3
$3.82M Sell
11,850
-114
-1% -$37.3K 1.58% 12
2024
Q2
$3.74M Buy
11,964
+178
+2% +$52.3K 1.62% 10
2024
Q1
$3.35M Buy
11,786
+210
+2% +$61.4K 1.5% 13
2023
Q4
$3.33M Buy
11,576
+145
+1% +$39.5K 1.63% 12
2023
Q3
$3.07M Sell
11,431
-725
-6% -$181K 1.69% 12
2023
Q2
$2.7M Sell
12,156
-1,923
-14% -$446K 1.29% 18
2023
Q1
$3.4M Sell
14,079
-291
-2% -$71.4K 1.69% 17
2022
Q4
$3.77M Sell
14,370
-116
-0.8% -$31.1K 1.87% 12
2022
Q3
$3.27M Sell
14,486
-99
-0.7% -$24K 1.77% 13
2022
Q2
$3.55M Sell
14,585
-238
-2% -$58.3K 1.8% 17
2022
Q1
$3.58M Buy
14,823
+175
+1% +$40.2K 1.54% 19
2021
Q4
$3.29M Sell
14,648
-286
-2% -$60.4K 1.34% 23
2021
Q3
$3.17M Sell
14,934
-315
-2% -$72.5K 1.44% 21
2021
Q2
$3.72M Buy
15,249
+62
+0.4% +$15.3K 1.65% 19
2021
Q1
$3.78M Sell
15,187
-231
-1% -$55.1K 1.74% 15
2020
Q4
$3.54M Sell
15,418
-76
-0.5% -$17.5K 1.74% 16
2020
Q3
$3.94M Sell
15,494
-404
-3% -$100K 2.1% 7
2020
Q2
$3.75M Buy
15,898
+115
+0.7% +$26.2K 2.13% 10
2020
Q1
$3.2M Sell
15,783
-350
-2% -$76.4K 1.75% 9
2019
Q4
$3.89M Buy
16,133
+209
+1% +$46.1K 1.54% 13
2019
Q3
$3.08M Sell
15,924
-490
-3% -$94.1K 1.36% 17
2019
Q2
$3.02M Sell
16,414
-214
-1% -$38.3K 1.32% 16
2019
Q1
$3.16M Buy
16,628
+60
+0.4% +$11.5K 1.38% 14
2018
Q4
$3.23M Buy
16,568
+40
+0.2% +$7.8K 1.63% 12
2018
Q3
$3.43M Sell
16,528
-416
-2% -$82K 1.36% 14
2018
Q2
$3.13M Buy
16,944
+53
+0.3% +$9.38K 1.23% 14
2018
Q1
$2.88M Sell
16,891
-1,377
-8% -$253K 1.14% 17
2017
Q4
$3.18M Sell
18,268
-456
-2% -$80.7K 1.2% 15
2017
Q3
$3.49M Sell
18,724
-370
-2% -$65.6K 1.44% 9
2017
Q2
$3.29M Sell
19,094
-399
-2% -$64.9K 1.17% 13
2017
Q1
$3.2M Sell
19,493
-845
-4% -$140K 1.03% 14
2016
Q4
$2.97M Sell
20,338
-190
-0.9% -$28.6K 0.97% 15
2016
Q3
$3.42M Buy
20,528
+139
+0.7% +$23.5K 1.24% 11
2016
Q2
$3.1M Buy
20,389
+1,808
+10% +$281K 1.13% 14
2016
Q1
$2.79M Buy
18,581
+1,800
+11% +$267K 1.01% 14
2015
Q4
$2.72M Buy
16,781
+1,615
+11% +$254K 0.95% 14
2015
Q3
$2.1M Buy
15,166
+698
+5% +$110K 0.8% 16
2015
Q2
$2.22M Buy
14,468
+1,630
+13% +$261K 0.77% 16
2015
Q1
$2.05M Buy
12,838
+805
+7% +$127K 0.74% 17
2014
Q4
$1.92M Sell
12,033
-135
-1% -$21K 0.66% 19
2014
Q3
$1.71M Buy
12,168
+350
+3% +$45.7K 0.64% 22
2014
Q2
$1.4M Buy
11,818
+1,330
+13% +$154K 0.49% 28
2014
Q1
$1.29M Buy
10,488
+1,570
+18% +$190K 0.47% 29
2013
Q4
$1.02M Buy
8,918
+615
+7% +$70K 0.39% 33
2013
Q3
$928K Buy
8,303
+5,040
+154% +$546K 0.4% 32
2013
Q2
$322K Buy
+3,263
New +$339K 0.24% 37

Other funds holding AMGN

Bank OZK's AMGN Position: Q1 2026 in Review

Bank OZK increased its Amgen (AMGN) stake by 0.66% in Q1 2026, buying an estimated $30.3K and bringing the position to 12,893 shares worth $4.54M. The position accounts for 1.6% of the portfolio, ranked #14.

Bank OZK first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank OZK held 12,893 shares of Amgen worth $4.54M as of Q1 2026.
  • Bank OZK bought 85 Amgen shares in Q1 2026, an estimated $30.3K.
  • Amgen made up 1.6% of Bank OZK's portfolio in Q1 2026, its #14 holding.
  • Bank OZK first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.